Clinical Study of BDB018: Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
Clinical trial NCT04840394 · COMPLETED
Trial details
- NCT number
- NCT04840394
- Sponsor
- Eikon Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-22
- Primary completion
- 2024-03-31
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.